Page last updated: 2024-11-01

niflumic acid and Sjogren's Syndrome

niflumic acid has been researched along with Sjogren's Syndrome in 1 studies

Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.

Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"In most cases, Sweet's syndrome may occur in the absence of other diseases."1.34[Sweet's syndrome: a propos of 8 cases]. ( Ayed, MB; Benmously, R; Debbiche, A; Fenniche, S; Marrek, H; Mokhtar, I; Souissi, A; Zarrouk, M, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Souissi, A1
Benmously, R1
Fenniche, S1
Zarrouk, M1
Marrek, H1
Debbiche, A1
Ayed, MB1
Mokhtar, I1

Other Studies

1 other study available for niflumic acid and Sjogren's Syndrome

ArticleYear
[Sweet's syndrome: a propos of 8 cases].
    La Tunisie medicale, 2007, Volume: 85, Issue:1

    Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Anti-Inflammatory Agents, N

2007